Cite Filings / MLTX / 0001628280-23-009529

Feed Companies Filings Check

Sign in

424B3

Prospectus

MoonLake Immunotherapeutics Filed 2023-03-28 Acc 0001628280-23-009529

Documents 1

424B3 Prospectus , moonlake424b3.htm

Around this filing

2023-06-27 424B3 Prospectus
2023-03-31 SC 13G Amended Statement of Ownership
2023-03-28 424B3 Prospectus
2023-03-27 EFFECT Notice of Effectiveness
2023-03-22 4 10% owner bought 827,100 shares at an average $20.28 ($16,774,846)
2022-11-14 424B3 Prospectus

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading moonlake424b3.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…